Director John W. Rogers Jr. receives equity award in Ryan Specialty (RYAN)
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ROGERS JOHN W JR reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings director John W. Rogers Jr. received an award of 5,757 shares of Class A Common Stock in the form of Restricted Stock Units that vested immediately upon grant. He elected to defer settlement of these units until his separation from the board of directors, consistent with the company’s director compensation program.
Following this award, he directly holds or has deferred rights tied to a total of 110,433 shares, which includes 15,270 previously granted Restricted Stock Units that also vested immediately upon grant and are similarly deferred until he leaves board service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
ROGERS JOHN W JR
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 5,757 | $0.00 | -- |
Holdings After Transaction:
Class A Common Stock — 110,433 shares (Direct, null)
Footnotes (1)
- The reported securities represent Restricted Stock Units that vested immediately upon grant for which the reporting person has elected to defer settlement until their separation from service on the board of directors. Such grant was approved by the Board of the Issuer for purposes of Rule 16(b)(3). Includes 15,270 Restricted Stock Units that vested immediately upon grant for which the reporting person has elected to defer settlement until their separation from service on the board of directors.
Key Figures
RSU award: 5,757 shares
Total direct position: 110,433 shares
Previously granted RSUs: 15,270 units
+1 more
4 metrics
RSU award
5,757 shares
Restricted Stock Units vested immediately on April 28, 2026
Total direct position
110,433 shares
Shares and RSUs following the reported transaction
Previously granted RSUs
15,270 units
Earlier RSUs that vested immediately and are deferred to separation
Grant price
$0.00 per share
Equity compensation award, not an open-market purchase
Key Terms
Restricted Stock Units, defer settlement, Rule 16(b)(3)
3 terms
Restricted Stock Units financial
"The reported securities represent Restricted Stock Units that vested immediately upon grant"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
defer settlement financial
"the reporting person has elected to defer settlement until their separation from service"
Rule 16(b)(3) regulatory
"Such grant was approved by the Board of the Issuer for purposes of Rule 16(b)(3)."
FAQ
What did Ryan Specialty (RYAN) director John W. Rogers Jr. report on this Form 4?
He reported receiving 5,757 shares of Class A Common Stock as a Restricted Stock Unit award. The units vested immediately, but he elected to defer settlement until he leaves the board, reflecting standard equity-based director compensation rather than an open-market stock purchase.
Was the Ryan Specialty (RYAN) Form 4 transaction an open-market stock purchase?
No. The filing describes a grant of 5,757 Restricted Stock Units with a reported price of $0.00 per share. These units represent equity compensation approved by the board, not shares bought in the open market by the director at a cash price.
When will the Restricted Stock Units reported by John W. Rogers Jr. in RYAN’s Form 4 be settled?
Both the newly reported 5,757 units and 15,270 prior units vested immediately but will be settled after he separates from service on the board. Until that time, settlement is deferred according to his election under the company’s director compensation arrangements.
What is the significance of Rule 16(b)(3) in the Ryan Specialty (RYAN) Form 4 filing?
The footnote states the grant was approved by the issuer’s board for purposes of Rule 16(b)(3). This indicates the award was structured and approved to fit within an exemption framework for short-swing profit rules that apply to directors and other insiders under U.S. securities law.